Group name
TBx patients
Groups remarks
targeted prostate biopsy
T2a
16 (12.4)
T2b
3 (2.3)
T2c
64 (49.6)
T3a
40 (31.0)
>T3b
6 (4.7)
remark
Pathological stage,n (%)